Company Profiles

driven by the PitchBook Platform

Ivantis

Description

Developer of a surgical device for the treatment of glaucoma and other eye diseases. The company offers a minimally invasive microsurgical procedure that reduces eye pressure by re-establishing the patient's natural outflow pathway.

2007

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$25M

Latest Deal Amount

$133M

Total Amount Raised

Description

Developer of a surgical device for the treatment of glaucoma and other eye diseases. The company offers a minimally invasive microsurgical procedure that reduces eye pressure by re-establishing the patient's natural outflow pathway.

Website:

www.ivantisinc.com

Formerly Known As

Denali Vision

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Surgical Devices

Primary Office

38 Discovery Suite 150 Irvine, CA 92618United States
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Ivantis's full profile, request a free trial.

    Ivantis Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Ivantis Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Ivantis Investors (11)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Ascension VenturesGrowth/ExpansionMinority000 0000000 0000
    Biomedical Sciences Investment FundVenture CapitalMinority000 0000000 0000
    Delphi VenturesVenture CapitalMinority000 0000000 0000
    EDB InvestmentsCorporate Venture CapitalMinority000 0000000 0000
    Foresite Capital ManagementGrowth/ExpansionMinority000 0000000 0000
    Ascension Ventures Growth/Expansion
    Biomedical Sciences Investment Fund Venture Capital
    Delphi Ventures Venture Capital
    EDB Investments Corporate Venture Capital
    Foresite Capital Management Growth/Expansion

    Ivantis Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Dave Van MeterPresident, Chief Executive Officer and Chairman
    Brett TrauthenChief Scientific Officer
    Brandon LorrySenior Director
    Kenneth GaltVice President, Research & Development
    Dave Van Meter President, Chief Executive Officer and Chairman
    Brett Trauthen Chief Scientific Officer
    Brandon Lorry Senior Director
    Kenneth Galt Vice President, Research & Development

    Ivantis Board Members (11)

    NameRepresentingRoleSinceContact
    Info
    Ali Behbahani MDNew Enterprise AssociatesPartner000 0000
    Ben GustGBS Venture PartnersPartner000 0000
    Brant HeiseMemorialCare Innovation FundManaging Director, Vice President & Board Member000 0000
    Christopher Shen MDVertex Venture HoldingsBoard Member000 0000
    Douglas RoederDelphi VenturesManaging member000 0000
    Ali Behbahani MD Partner New Enterprise Associates
    Ben Gust Partner GBS Venture Partners
    Brant Heise Managing Director, Vice President & Board Member MemorialCare Innovation Fund
    Christopher Shen MD Board Member Vertex Venture Holdings
    Douglas Roeder Managing member Delphi Ventures
    Request full access to PitchBook